MSTN and Alzheimer disease: Among genes sharing the first profile (under-expression in active wild-type and active myostatin-reduced relative to inactive myostatin-reduced and similar expression levels across all other activity-genotype groups), KEGG pathways for several inflammation-associated neurodegenerative conditions including Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease were enriched.